Modified stent useful for delivery of drugs along stent strut
US6273913A · kind A · utility
817Cited by
12References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 1998 |
| Grant date | Aug 14, 2001 |
| Priority date | — |
| Expiry date | Apr 16, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/606
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Delivery of rapamycin locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.